Your browser is no longer supported. Please, upgrade your browser.
AEMD Aethlon Medical, Inc. daily Stock Chart
AEMD [NASD]
Aethlon Medical, Inc.
Index- P/E- EPS (ttm)-3.42 Insider Own1.30% Shs Outstand8.20M Perf Week4.21%
Market Cap23.30M Forward P/E- EPS next Y-0.39 Insider Trans0.00% Shs Float- Perf Month37.50%
Income-6.40M PEG- EPS next Q- Inst Own11.20% Short Float- Perf Quarter46.67%
Sales0.70M P/S33.29 EPS this Y63.60% Inst Trans- Short Ratio0.28 Perf Half Y135.15%
Book/sh1.15 P/B1.72 EPS next Y- ROA-132.20% Target Price- Perf Year-63.19%
Cash/sh0.82 P/C2.43 EPS next 5Y- ROE-174.20% 52W Range0.76 - 6.89 Perf YTD105.61%
Dividend- P/FCF- EPS past 5Y36.60% ROI-67.80% 52W High-72.13% Beta0.67
Dividend %- Quick Ratio9.40 Sales past 5Y-3.10% Gross Margin- 52W Low151.31% ATR0.27
Employees8 Current Ratio9.40 Sales Q/Q100.00% Oper. Margin- RSI (14)52.92 Volatility8.09% 14.69%
OptionableNo Debt/Eq0.00 EPS Q/Q83.30% Profit Margin- Rel Volume0.48 Prev Close1.98
ShortableYes LT Debt/Eq0.00 EarningsJun 25 AMC Payout- Avg Volume2.52M Price1.92
Recom2.00 SMA20-2.04% SMA5020.08% SMA200-17.49% Volume319,969 Change-3.03%
Jun-30-20 09:21AM  
Jun-25-20 04:15PM  
02:30PM  
Jun-22-20 08:31AM  
Jun-18-20 12:49PM  
09:19AM  
Jun-16-20 08:30AM  
Mar-24-20 08:58AM  
Mar-06-20 12:08PM  
Feb-25-20 03:25PM  
Feb-24-20 10:22AM  
Feb-17-20 01:37PM  
Feb-13-20 05:35AM  
Feb-10-20 04:15PM  
09:01AM  
Feb-06-20 08:01AM  
Jan-23-20 01:02PM  
09:51AM  
Jan-22-20 02:28PM  
01:16PM  
08:12AM  
Jan-21-20 02:40PM  
Jan-17-20 08:49AM  
Dec-17-19 04:18PM  
Dec-13-19 07:00AM  
Nov-15-19 05:04AM  
Nov-01-19 04:15PM  
Oct-29-19 03:17PM  
Oct-28-19 07:00AM  
Oct-14-19 03:55PM  
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.